Table 1 Demographic and Clinical Characteristics of Chinese Subjects Aged over 65 Years Stratified by Gender.

From: Higher prevalence of elevated LDL-C than non-HDL-C and low statin treatment rate in elderly community-dwelling Chinese with high cardiovascular risk

Ā 

All (3950)

Men (1745)

Women (2205)

P value

Gender (%)

Ā 

44.22

55.81

Ā 

Age (years)

71.96 (71.75ā€“72.16)

71.76 (71.46ā€“72.07)

72.11 (71.83ā€“72.39)

0.097

Education, % (n)

Ā Ā Ā 

<0.01

<6 year

41.74 (1649)

24.34 (425)

55.51 (1224)

Ā 

6ā€“12year

48.09 (1900)

58.48 (1021)

39.86 (879)

Ā 

>12 year

10.17 (402)

17.18 (300)

4.63 (102)

Ā 

Health habits

ā€ƒCurrent cigarette user, % (n)

14.07 (556)

30.58 (534)

1.00 (22)

<0.01

ā€ƒCurrent alcohol user, % (n)

13.71 (542)

29.32 ( 512)

1.36 (30)

<0.01

Definite hypertension, % (n)

75.08 (2966)

74.21 (1295)

75.78 (1671)

0.267

SBP, mmHg

138.8 (138.3ā€“139.3)

138.4 (137.6ā€“139.3)

139.1 (138.4ā€“139.8)

0.237

DBP, mmHg

81.8 (81.5ā€“82.1)

82.5 (82.1ā€“82.9)

81.3 (80.9ā€“81.7)

<0.01

BMI, kg/m2

24.62 (24.51ā€“24.72)

24.46 (24.31ā€“24.61)

24.74 (24.59ā€“24.89)

0.011

Definite diabetes, % (n)

20.73 (819)

19.71 (344)

21.54 (475)

0.156

Awareness of Diabetes, % (n)

78.38 (642)

80.52 (277)

76.84 (365)

0.119

Treatment of Diabetes, % (n)

13.77 (544)

13.69 (239)

13.83 (305)

0.926

FG, mmol/l

5.76 (5.70ā€“5.81)

5.68 (5.59ā€“5.76)

5.82 (5.74ā€“5.90)

0.018

HbA1c, %

6.35 (6.32ā€“6.39)

6.30 (6.25ā€“6.35)

6.39 (6.35ā€“6.44)

<0.01

ā€ƒā‰„6.5, %

25.82 (1020)

24.24 (423)

27.07 (597)

0.044

ā€ƒā‰„7.0, %

15.87 (627)

14.72 (257)

16.78 (370)

0.087

Established CVDā€ 

7.77 (307)

9.16 (160)

6.66 (147)

0.056

Lipid profile

ā€ƒStatin treatment, % (n)

5.31 (210)

5.67 (99)

5.03 (111)

0.392

ā€ƒTC, mmol/l

4.98 (4.95ā€“5.01)

4.72 (4.67ā€“4.76)

5.20 (5.16ā€“5.24)

<0.01

ā€ƒLDL-C, mmol/l

3.30 (3.28ā€“3.33)

3.12 (3.08ā€“3.16)

3.45 (3.41ā€“3.49)

<0.01

ā€ƒHDL-C, mmol/l

1.46 (1.45ā€“1.47)

1.38 (1.36ā€“1.40)

1.52 (1.51ā€“1.54)

<0.01

ā€ƒTG, mmol/l

1.63 (1.59ā€“1.66)

1.53 (1.47ā€“1.58)

1.71 (1.66ā€“1.76)

<0.01

ā€ƒNon-HDL-C, mmol/l

3.52 (3.49ā€“3.55)

3.33 (3.29ā€“3.37)

3.67 (3.63ā€“3.71)

<0.01

  1. Values are mean and 95% confidence interval (CI), or percentages % (number).
  2. Percentage of treatment calculated as medication used in hypertension or diabetes.
  3. Established CVD includes history of MI, coronary or other arterial revascularization, stroke; definitive hypertension defined as SBP ā‰„140ā€‰mmHg or DBP ā‰„90ā€‰mmHg, or normal BP with concomitant use of antihypertensive medications; definitive diabetes as FG ā‰„7.0ā€‰mmol/L or normal blood glucose with concomitant use of hypoglycemic medications.
  4. SBP, systolic blood pressure; DBP, diastolic blood pressure; TC, total cholesterol; LDL-C, low density lipoprotein cholesterol; HDL-C, high density lipoprotein cholesterol; Non-HDL-C, sum of LDL-C and VLDL-C calculated as total-Cholesterol minus HDL-Cholesterol; TG, triglyceride; FG, fasting glucose.
  5. To convert from mmol/L to mg/dl, divide by 0.05551 for glucose, by 0.02586 for TC, HDL-C, and LDL-C, and by 0.01129 for triglycerides.
Back to article page